Estimation of atenolol by reverse phase high performance liquid chromatography

E-Journal of Chemistry

Volumn 7, Issue 3, 2010, Pages 962-966

  Kumar, Naveen ^a   Verma, Nishant ^a   Songh, Omveer ^a   Joshi, Naveen ^a   Singh, Kanwar Gaurav ^b  

^a SHOBHIT UNIVERSITY   (India)

^b Singhania University Pacheri Bari   (India)

Author keywords

Atenolol; HPLC; ODS; Validation

Indexed keywords

EID: 77957354321     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2010/601650     Document Type: Article

References (13)

1. Gajewska M, Glass G and Koste ecki J, Acta Pol Pharm., 1992, 49(3), 1-4.
2. Keech A C, Harrison P M and Mclean A J, J Chrom Biomed Appl., 1988, 70, 234-236.
3. Rao G R, Avadhanulu A B, Giridhar R, Pantalu R R and Kokate C K, East Pharm., 1990, 33(386), 125-126.
4. Shimoka K, Sawada Y and Teternatsu H, J Pharm Biomed Anal., 1989, 7(11), 1267-1272.
5. Indian Pharmacopoeia, Indian Pharmacopoeia Commission, 1996, 1, 73-75.
6. Arias R, Jim R M, Alonso R M, Lez M T, Arrieta I, Flores P and Lastra E O, J Chromatogr A, 2001, 916, 297-304.
7. Carl A G, The Comprehensive Pharmacology Reference, 2008, 1-6.
8. Johnell K and Fastbom J, Arch Osteoporos, 2009, 4(1-2), 17-23.
9. Agon P, Goethals P, Van Haver, D and Kaufman J M, J Pharm Pharmacol., 1991, 43, 597-600.
10. Krzesinski J M and Scheen A J, Rev Med Liege., 2009. 64(2), 103-108.
11. Knight C J and Fox K M, Am J Cardiol., 1998, 81(2), 133-136.
12. Lindgren P, Buxton M, Kahan T, Poulter N R, Dahlöf B, Sever P S, Wedel H and Jönsson B, Pharmacoeconomic, 2009, 27(3), 221-23.
13. Yamanaka S, Tatsumi T, Shiraishi J, Mano A, Keira N, Matoba S, Asayama J, Fushiki S, Fliss H and Nakagawa M, J Am Coll Cardiol., 2003, 41(5), 870-878.